In this webinar, Gareth will focus on immune-related adverse events (irAEs) associated with immune checkpoint inhibitors in primary care, noting that while systemic therapies are initiated by specialists, primary care practitioners need to be aware of and potentially manage irAEs.
Patient safety relies on the early recognition, investigation and management of irAEs and effective coordination between primary and secondary care.
Presenter
Gareth Rivalland
Gareth is a Medical Oncologist specialising in cutaneous and thoracic malignancies. He is the lead of the Melanoma team at Auckland Hospital and Medical Director at Harbour Cancer and Wellness Centre.
His focus is bringing cutting-edge treatments to New Zealanders having been the local principal investigator on a number of ground-breaking regional and global studies.
Supported by an unrestricted educational grant from:
